{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T03:50:10Z","timestamp":1784260210778,"version":"3.55.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Fondo Sectorial de Investigaci\u00f3n en Salud y Seguridad Social","award":["SSA\/IMSS\/ISSSTE-CONACYT I010\/801\/2014 CAR General 233256"],"award-info":[{"award-number":["SSA\/IMSS\/ISSSTE-CONACYT I010\/801\/2014 CAR General 233256"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","thrombosisresearch.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.thromres.2018.12.023","type":"journal-article","created":{"date-parts":[[2018,12,29]],"date-time":"2018-12-29T03:49:46Z","timestamp":1546055386000},"page":"141-147","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Prevalence and associations of anti-phosphatidylserine\/prothrombin antibodies with clinical phenotypes in patients with primary antiphospholipid syndrome"],"prefix":"10.1016","volume":"174","author":[{"given":"Carlos A.","family":"N\u00fa\u00f1ez-\u00c1lvarez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Hern\u00e1ndez-Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Berm\u00fadez-Bermejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Zamora-Legoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego F.","family":"Hern\u00e1ndez-Ram\u00edrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Olivares-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio R.","family":"Cabral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2018.12.023_bb0005","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2018.12.023_bb0010","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12948-016-0043-2","article-title":"Thrombotic risk assessment in antiphospholipid syndrome: the role of new antibody specificities and thrombin generation assay","volume":"14","author":"Sciasica","year":"2016","journal-title":"Clin. Mol. Allerg."},{"key":"10.1016\/j.thromres.2018.12.023_bb0015","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1160\/TH13-06-0509","article-title":"Anti-prothrombin and anti-phospatydyl-serine\/protrombin (aPS\/PT) antibodies and the risk of thrombosis in the antiphospholipid syndrome. A systematic review","volume":"111","author":"Siascia","year":"2014","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2018.12.023_bb0020","article-title":"Anti-phosphatidylserine\/prothrombin antibodies are associated with adverse pregnancy outcomes","author":"Zigon","year":"2015","journal-title":"J Immunol Res"},{"key":"10.1016\/j.thromres.2018.12.023_bb0025","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.blre.2008.03.005","article-title":"The hematologic manifestations of the antiphospholipid syndrome","volume":"22","author":"Uthman","year":"2008","journal-title":"Blood Rev."},{"key":"10.1016\/j.thromres.2018.12.023_bb0030","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1111\/j.1538-7836.2009.03555.x","article-title":"Update of the guidelines for lupus anticoagulant detection. Subcommittee on Lupus Anticoagulant\/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis","volume":"7","author":"Pengo","year":"2009","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2018.12.023_bb0035","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s11926-014-0415-x","article-title":"New test to detect antiphospholipid antibodies: antiprothrombin (aPT) and anti-phosphatidylserine\/prothrombin antibodies","volume":"16","author":"Sciascia","year":"2014","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.thromres.2018.12.023_bb0040","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1515\/cclm-2016-0638","article-title":"Antiphosphatidylserine\/prothrombin antibodies as biomarkers to identify severe primary antiphospholipid syndrome","volume":"55","author":"Hoxha","year":"2016","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.thromres.2018.12.023_bb0045","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1177\/0961203312441983","article-title":"Antiphosphatidylserine\/prothrombin antibodies in primary antiphospholipid syndrome","volume":"21","author":"Hoxha","year":"2012","journal-title":"Lupus"},{"key":"10.1016\/j.thromres.2018.12.023_bb0050","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1002\/1529-0131(200009)43:9<1982::AID-ANR9>3.0.CO;2-2","article-title":"Association of autoantibodies against the phosphatidylserine-prothrombin complex with manifestations of the antiphospholipid syndrome and with the presence of lupus anticoagulant","author":"Atsumi","year":"2000","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.thromres.2018.12.023_bb0055","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1160\/TH03-10-0608","article-title":"Strong correlation between the prevalence of cerebral infarction and the presence of anti-cardiolipin\/B2glycoprotein I and anti-phosphatidylserine\/prothrombin antibodies","volume":"91","author":"Nojima","year":"2004","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2018.12.023_bb0060","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1160\/TH04-06-0382","article-title":"Antiprothrombin antibodies detected in two different assay systems. Prevalence and clinical significance in systemic lupus erythematosus","volume":"93","author":"Bertolaccini","year":"2005","journal-title":"Thromb. Hemost."},{"key":"10.1016\/j.thromres.2018.12.023_bb0065","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1136\/ard.2005.035824","article-title":"Antiphospholipid antibody test: spreading the net","volume":"64","author":"Bertolaccini","year":"2005","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.thromres.2018.12.023_bb0070","doi-asserted-by":"crossref","first-page":"158","DOI":"10.3109\/s10165-006-0481-7","article-title":"Significance of antiprothrombin antibodies in patients with systemic lupus erythematosus: clinical evaluation of the antiprothormbin assay and the antiphosphatidylserine\/prothrombin assay, and comparison with other antiphospholipid antibody assays","volume":"16","author":"Tsutsumi","year":"2006","journal-title":"Mod. Rheumatol."},{"key":"10.1016\/j.thromres.2018.12.023_bb0075","first-page":"699","article-title":"The presence of anti-phosphatidylserine\/prothrombin antibodies as risk factor for both arterial and venous thrombosis in patients with systemic lupus erythematosus","volume":"91","author":"Nojima","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.thromres.2018.12.023_bb0080","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.imbio.2007.02.001","article-title":"Does the anti-prothrombin antibodies measurement provide additional information in patients with thrombosis?","volume":"212","author":"Bardin","year":"2007","journal-title":"Immunobiology"},{"key":"10.1016\/j.thromres.2018.12.023_bb0085","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1160\/TH12-07-0527","article-title":"Prevalence of antibodies to prothrombin in solid phase (aPT) and to phosphatidylserine-prothrombin complex (aPS\/PT) in patients with and without lupus anticoagulant","volume":"109","author":"Bertolaccini","year":"2013","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2018.12.023_bb0090","first-page":"289","article-title":"Antiphosphatidylserine\/prothrombin antibodies (aPS\/PT) as potential markers of antiphospholipid syndrome","volume":"19","author":"Vlagea","year":"2013","journal-title":"Thromb. Hemost."},{"key":"10.1016\/j.thromres.2018.12.023_bb0095","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.thromres.2013.12.001","article-title":"Validation of a commercially available kit to detect anti-phosphatidylserine\/prothrombin antibodies in a cohort of systemic lupus erythematosus patients","volume":"133","author":"Sciascia","year":"2014","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2018.12.023_bb0100","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1177\/0961203316660203","article-title":"Evaluation of phosphatidylserine-dependent antiprothrombin antibody testing for the diagnosis of antiphospholipid syndrome: results of an international multicentre study","volume":"26","author":"Amengual","year":"2017","journal-title":"Lupus"},{"issue":"56","key":"10.1016\/j.thromres.2018.12.023_bb0105","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1515\/cclm-2017-0502","article-title":"Antiphosphatidylserine\/prothrombin antibodies (aPs\/PT) as potential diagnostic markers and risk predictors of venous thrombosis and obstetric complications in antiphospholipid syndrome","volume":"28","author":"Shi","year":"2018","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.thromres.2018.12.023_bb0110","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1093\/rheumatology\/kes388","article-title":"GASPSS: the global anti-phospholipid syndrome score","volume":"52","author":"Sciascia","year":"2013","journal-title":"Rheumatology"},{"key":"10.1016\/j.thromres.2018.12.023_bb0115","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1182\/blood-2010-05-283507","article-title":"Antiphospholipid-associated thrombocytopenia or autoimmune hemolytic anemia in patients with or without definite primary antiphospholipid syndrome according to the Sapporo revised classification criteria: a 6-year follow-up study","volume":"116","author":"Comellas-Kirkerup","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2018.12.023_bb0120","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/cei.12573","article-title":"Laboratory evaluation of anti-phospholipid syndrome: a preliminary prospective study of phosphatidylserine\/prothrombin antibodies in an at-risk patient cohort","volume":"180","author":"Heikal","year":"2015","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.thromres.2018.12.023_bb0125","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s13317-014-0061-3","article-title":"The introduction of antiphosphatidylserine\/prothrombin autoantibodies in the laboratory diagnostic process of anti-phospholipid antibody syndrome: 6\u202fmonths of observation","volume":"5","author":"Fabris","year":"2014","journal-title":"Auto Immun High."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384818306728?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384818306728?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,29]],"date-time":"2019-01-29T16:52:39Z","timestamp":1548780759000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384818306728"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":25,"alternative-id":["S0049384818306728"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2018.12.023","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence and associations of anti-phosphatidylserine\/prothrombin antibodies with clinical phenotypes in patients with primary antiphospholipid syndrome","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2018.12.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}